Listed

Brady Corp: Form 10-Q for the period ended Oct 31, 2022

Filed with the SEC on Nov 17, 2022 and accepted by EDGAR at Nov 17, 2022, 07:15 ET.

Share

Management's discussion and analysis

As filed, 23,862 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Brady Corporation is a global manufacturer and supplier of identification solutions and workplace safety products that identify and protect premises, products and people. The IDS segment is primarily involved in the design, manufacture, and distribution of high-performance and innovative identification and healthcare products. The WPS segment manufactures a broad range of stock and custom identification products and sells a broad range of resale products.

The ability to provide customers with a broad range of proprietary, customized and diverse products for use in various applications across multiple industries and geographies, along with a commitment to quality and service, have made Brady a leader in many of its markets. Brady's long-term sales growth and profitability will depend not only on the overall economic environment and our ability to successfully navigate changes in the macro environment, but also on our ability to develop and market innovative new products, deliver a high level of customer service, advance our digital capabilities, and continuously improve the efficiency of our global operations. In our IDS business, our strategy for growth includes an increased focus on certain industries and products, a focus on improving the customer buying experience, and the development of technologically advanced, innovative and proprietary products. In our WPS business, our strategy for growth includes a focus on workplace safety critical industries, streamlining our product offerings, compliance expertise, customization expertise, improving the overall customer experience, and improving our digital capabilities.

The following are key initiatives supporting our strategy in fiscal 2023:

  • Investing in organic growth by enhancing our research and development process and utilizing customer feedback and observations to develop innovative new products that solve customer needs and improve environmental sustainability.
  • Providing our customers with the highest level of customer service.
  • Expanding and enhancing our sales capabilities through an improved digital presence and the use of data-driven marketing automation tools.
  • Maintaining profitability through pricing mechanisms to mitigate the impacts of supply chain disruptions and inflationary pressures while ensuring prices are market competitive.
  • Investing in acquisitions that enhance our strategic position and accelerate long-term sales growth.
  • Driving operational excellence and executing sustainable efficiency gains within our selling, general and administrative structures and within our global operations including insourcing of critical products and manufacturing activities while reducing our environmental footprint and managing working capital.
  • Building on our culture of diversity, equity and inclusion to increase employee engagement and enhance recruitment and retention practices in order to drive differentiated performance and execute our strategy.

Impact of the COVID-19 Pandemic and other Global Geopolitical Events on Our Business

The Company has experienced, and expects to continue to experience, increased freight and input material cost inflation as a result of increased global demand, disruptions caused by COVID-19 and government-mandated actions in response to COVID-19, the conflict in the Ukraine, as well as labor shortages. The Company has taken and will continue to take actions to mitigate inflation issues, but thus far has not fully offset the impact of these trends through pricing actions. As a result, these trends have negatively impacted the Company's gross profit margin.

We believe we have the financial strength to continue to invest in organic sales growth opportunities including sales, marketing, and research and development ("R&D") and inorganic sales opportunities including acquisitions, while continuing to drive sustainable efficiency gains and automation in our operations and selling, general and administrative ("SG&A") functions. At October 31, 2022, we had cash of $114.5 million, as well as a credit facility with $99.4 million available for future borrowing, which can be increased up to $299.4 million at the Company's option and subject to certain conditions, for total available liquidity of $413.9 million.

We believe that our financial resources and liquidity levels including the remaining undrawn amount of the credit facility and our ability to increase that credit line as necessary are sufficient to manage the continuing impact of geopolitical events which may result in reduced sales, reduced net income, and reduced cash provided by operating activities. Refer to Risk Factors, included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended July 31, 2022, for further discussion of the possible impact of the COVID-19 pandemic and other global geopolitical events on our business.

Results of Operations

A comparison of results of operating income for the three months ended October 31, 2022 and 2021 is as follows:

(Dollars in thousands)

Three months ended October 31, 2022 % Sales 2021 % Sales
Net sales $322,569 $321,475
Gross margin 155,264 48.1% 154,988 48.2%
Operating expenses:
Research and development 13,933 4.3% 13,907 4.3%
Selling, general and administrative 89,945 27.9% 96,746 30.1%
Total operating expenses 103,878 32.2% 110,653 34.4%
Operating income $51,386 15.9% $44,335 13.8%

References in this Form 10-Q to “organic sales” refer to sales calculated in accordance with GAAP, excluding the impact of foreign currency translation and sales recorded from acquired companies prior to the first anniversary date of their acquisition. The Company's organic sales disclosures exclude the effects of foreign currency translation as foreign currency translation is subject to volatility that can obscure underlying business trends. Management believes that the non-GAAP financial measure of organic sales is meaningful to investors as it provides them with useful information to aid in identifying underlying sales trends in our businesses and facilitating comparisons of our sales performance with prior periods.

Net sales for the three months ended October 31, 2022, increased 0.3% to $322.6 million, compared to $321.5 million in the same period in the prior year. The increase consisted of organic sales growth of 6.9% partially offset by a decrease from foreign currency translation of 6.6%. Organic sales grew 8.6% in the IDS segment and grew 1.2% in the WPS segment during the three months ended October 31, 2022, compared to the same period in the prior year.

Gross margin increased 0.2% to $155.3 million in the three months ended October 31, 2022, compared to $155.0 million in the same period in the prior year. As a percentage of net sales, gross margin decreased to 48.1% compared to 48.2% in the same period in the prior year. The decrease in gross margin as a percentage of net sales was primarily due to an increase in the cost of materials and labor, which was partially mitigated by price increases as well as our ongoing efforts to streamline manufacturing processes and drive sustainable operational efficiencies.

R&D expenses were consistent at $13.9 million and 4.3% of sales in the three months ended October 31, 2022 and 2021. The Company remains committed to investing in new product development to increase sales within our IDS and WPS businesses. Investments in new printing systems, materials and the build out of a comprehensive industrial track and trace solution remain the primary focus of R&D expenditures for the remainder of fiscal 2023.

SG&A expenses include selling and administrative costs directly attributed to the IDS and WPS segments, as well as certain other corporate administrative expenses including finance, information technology, human resources, and other administrative expenses. SG&A expenses decreased 7.0% to $89.9 million in the three months ended October 31, 2022, compared to $96.7 million in the same period in the prior year. As a percentage of sales, SG&A decreased to 27.9% for the three months ended October 31, 2022, compared to 30.1% in the same period in the prior year. The decrease in SG&A expenses was primarily due to foreign currency translation and to a lesser extent, reductions in catalog advertising expenses within the WPS segment.

Operating income increased 15.9% to $51.4 million in the three months ended October 31, 2022, compared to $44.3 million in the same period in the prior year. The increase in operating income was due to an increase in segment profit in the WPS business due to actions taken last fiscal year to reduce the cost structure along with ongoing reductions in catalog advertising expenses, as well as an increase in IDS segment profit resulting from organic sales growth.

OPERATING INCOME TO NET INCOME

(Dollars in thousands)

Three months ended October 31, 2022 % Sales 2021 % Sales
Operating income $51,386 15.9% $44,335 13.8%
Other (expense) income:
Investment and other (expense) income (157) 0.0% 543 0.2%
Interest expense (894) (0.3)% (182) (0.1)%
Income before income taxes 50,335 15.6% 44,696 13.9%
Income tax expense 10,894 3.4% 9,650 3.0%
Net income $39,441 12.2% $35,046 10.9%

Investment and other expense was $0.2 million in the three months ended October 31, 2022, compared to investment and other income of $0.5 million in the same period in the prior year. The change was primarily due to a decrease in the market value of securities held in deferred compensation plans during the three months ended October 31, 2022.

Interest expense increased to $0.9 million in the three months ended October 31, 2022, compared to $0.2 million in the same period in the prior year. The increase in interest expense was primarily due to an increase in interest rates in the Company's revolving loan agreement and partially due to an increase in outstanding borrowings on the Company's revolving loan agreement compared to the same period in the prior year.

The Company’s income tax rate was 21.6% for the three months ended October 31, 2022 and 2021. Refer to Note M "Income Taxes" for additional information on the Company's income tax rate.

Business Segment Operating Results

The Company evaluates short-term segment performance based on segment profit and customer sales. Interest expense, investment and other (expense) income, income tax expense, and certain corporate administrative expenses are excluded when evaluating segment performance.

The following is a summary of segment information for the three months ended October 31, 2022 and 2021:

SALES GROWTH INFORMATION IDS Three months ended October 31, 2022 2021
Organic 8.6% 13.2%
Currency (5.5)% 0.6%
Acquisitions —% 11.6%
Total 3.1% 25.4%
WPS
Organic 1.2% (8.6)%
Currency (10.3)% 0.8%
Total (9.1)% (7.8)%
Total Company
Organic 6.9% 7.0%
Currency (6.6)% 0.7%
Acquisitions —% 8.3%
Total 0.3% 16.0%
SEGMENT PROFIT
IDS $51,525 $48,816
WPS 6,378 2,293
Total $57,903 $51,109
SEGMENT PROFIT AS A PERCENT OF NET SALES
IDS 20.1% 19.6%
WPS 9.6% 3.1%
Total 18.0% 15.9%

19

IDS

IDS net sales increased 3.1% to $256.4 million in the three months ended October 31, 2022, compared to $248.6 million in the same period in the prior year, which consisted of organic sales growth of 8.6% and a decrease from foreign currency translation of 5.5%. Organic sales grew in all major product lines with the most significant growth in the safety and facility identification product line, followed by growth in the product identification, wire identification and healthcare identification product lines.

Organic sales in the Americas increased in the mid-single digits, organic sales in Europe increased in the mid-teens, and organic sales in Asia increased in the mid-single digits in the three months ended October 31, 2022 compared to the same period in the prior year.

Segment profit increased 5.5% to $51.5 million in the three months ended October 31, 2022, compared to $48.8 million in the same period in the prior year. As a percentage of net sales, segment profit was 20.1% compared to 19.6% in the same period in the prior year. The increase in segment profit was primarily due to increased sales volumes in all regions and all major product lines globally.

WPS

WPS net sales declined 9.1% to $66.2 million in the three months ended October 31, 2022, compared to $72.9 million in the same period in the prior year, which consisted of an organic sales increase of 1.2% and a decrease from foreign currency translation of 10.3%. Organic digital sales increased by nearly 13% and organic catalog sales declined in the low-single digits in the three-month period.

Organic sales in Europe increased in the mid-single digits consisting of digital sales growth of approximately 10% and low-single digit catalog channel sales growth. Organic sales in North America declined by approximately 11% primarily due to actions taken to improve price competitiveness and simplify our product offering, which contributed to the significant improvement in segment profit in the three-month period. Organic sales in Australia increased by approximately 11% in the three months ended October 31, 2022 compared to the same period in the prior year consisting of high-single digit digital sales growth and catalog channel sales growth of approximately 12%.

Segment profit increased 178.2% to $6.4 million in the three months ended October 31, 2022, compared to $2.3 million in the same period of the prior year. As a percentage of net sales, segment profit improved to 9.6% compared to 3.1% in the same period of the prior year. The increase in segment profit was primarily due to actions taken during fiscal 2022 to reduce the cost structure as well as ongoing reductions in catalog advertising expenses.

Liquidity and Capital Resources

The Company's cash balances are generated and held in numerous locations throughout the world. At October 31, 2022, approximately 95% of the Company's cash and cash equivalents were held outside the United States. The Company's organic and inorganic growth has historically been funded by a combination of cash provided by operating activities and debt financing. The Company believes that its cash flow from operating activities and its borrowing capacity are sufficient to fund its anticipated requirements for working capital, capital expenditures, research and development, common stock repurchases, and dividend payments for the next 12 months. Although the Company believes these sources of cash are currently sufficient to fund domestic operations, annual cash needs could require repatriation of cash to the U.S. from foreign jurisdictions, which may result in additional tax payments.

Cash Flows

Cash and cash equivalents were $114.5 million at October 31, 2022, an increase of $0.4 million from July 31, 2022. The significant changes were as follows:

(Dollars in thousands)

Net cash flow provided by (used in): Three months ended October 31, 2022 2021
Operating activities $27,999 $27,491
Investing activities (3,861) (11,326)
Financing activities (20,535) (4,592)
Effect of exchange rate changes on cash (3,201) (1,355)
Net increase in cash and cash equivalents $402 $10,218

20

Net cash provided by operating activities was $28.0 million in the three months ended October 31, 2022, compared to $27.5 million in the same period of the prior year. The use of cash from working capital was reduced primarily due to a decrease in the amount of inventory purchases in the current quarter, which was offset by the annual cash incentive plan payment made in the current quarter compared to the second quarter of the prior year.

Net cash used in investing activities consisted of $3.9 million of capital expenditures in the three months ended October 31, 2022, compared to $11.3 million of capital expenditures in the same period of the prior year. Prior year capital expenditures were elevated due to the purchase of two facilities that were previously leased.

Net cash used in financing activities was $20.5 million in the three months ended October 31, 2022 compared to $4.6 million in the same period of the prior year. Net borrowings on the credit facility declined by $25.0 million primarily due to reduced capital expenditures and share repurchases in the three months ended October 31, 2022 compared to the same period in the prior year.

Material Cash Requirements

Our material cash requirements for known contractual obligations include capital expenditures, borrowings on credit facilities and lease obligations. We believe that net cash provided by operating activities will continue to be adequate to meet our liquidity and capital needs for these items over the short-term in the next 12 months and in the long-term beyond the next 12 months. We also have cash requirements for purchase orders and contracts for the purchase of inventory and other goods and services, which are based on current and anticipated customer needs and are fulfilled by our suppliers within short time horizons. We do not have significant agreements for the purchase of inventory or other goods or services specifying minimum order quantities. In addition, we may have liabilities for uncertain tax positions, but we do not believe that the cash requirements to meet any of these liabilities will be material.

Credit Facilities

On August 1, 2019, the Company and certain of its subsidiaries entered into an unsecured $200 million multi-currency revolving loan agreement with a group of five banks. At the Company's option, and subject to certain conditions, the available amount under the revolving loan agreement may be increased from $200 million to $400 million.

On December 21, 2021, the Company and certain of its subsidiaries entered into an amendment to the revolving loan agreement, which amends the revolving loan agreement dated August 1, 2019. The amendment amends the revolving loan agreement to, among other items, (a) change the interest rate under the revolving loan agreement for borrowings (i) denominated in British Pounds from the London Inter-bank Offered Rate ("LIBOR") to a daily simple SONIA-based rate, (ii) denominated in Euro from a LIBOR-based rate to a rate based on the Euro Interbank Offered Rate and (iii) denominated in Japanese Yen from a LIBOR-based rate to a rate based on the Tokyo Interbank Offered Rate, in each of the foregoing cases subject to certain adjustments specified in the revolving loan agreement; and (b) provide mechanics relating to a transition away from U.S. dollar LIBOR (with respect to borrowings denominated in U.S. dollars) and the designated benchmarks for the other eligible currencies as benchmark interest rates and the replacement of any such benchmark by a replacement benchmark rate. The amendment to the revolving loan agreement did not have a material impact on the interest rate or related balances in the Company's consolidated financial statements.

As of October 31, 2022, the outstanding balance on the Company's revolving loan agreement was $99.0 million. The maximum amount outstanding on the credit facility during the three months ended October 31, 2022 was $101.0 million. The borrowings bear interest at 4.09% as of October 31, 2022. The Company had letters of credit outstanding under the loan agreement of $1.6 million as of October 31, 2022 and there was $99.4 million available for future borrowing, which can be increased to $299.4 million at the Company's option, subject to certain conditions. The revolving loan agreement has a final maturity date of August 1, 2024. As such, borrowings were classified as long-term on the Condensed Consolidated Balance Sheets.

Refer to Item 1, Note N, "Subsequent Events" for information regarding the Company's subsequent events affecting financial condition.

Covenant Compliance

The Company's revolving loan agreement requires it to maintain certain financial covenants, including a ratio of debt to the trailing twelve months EBITDA, as defined in the debt agreements, of not more than a 3.5 to 1.0 ratio (leverage ratio) and the trailing twelve months EBITDA to interest expense of not less than a 3.0 to 1.0 ratio (interest expense coverage). As of October 31, 2022, the Company was in compliance with these financial covenants, with a ratio of debt to EBITDA, as defined by the agreements, equal to 0.38 to 1.0 and the interest expense coverage ratio equal to 125.1 to 1.0.

Forward-Looking Statements

In this quarterly report on Form 10-Q, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:

  • Increased cost of raw materials, labor and freight as well as raw material shortages and supply chain disruptions
  • Adverse impacts of the novel coronavirus ("COVID-19") pandemic or other pandemics
  • Decreased demand for the Company's products
  • Ability to compete effectively or to successfully execute its strategy
  • Ability to develop technologically advanced products that meet customer demands
  • Ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses
  • Difficulties in protecting websites, networks, and systems against security breaches and difficulties in preventing phishing attacks, social engineering or malicious break-ins.
  • Risks associated with the loss of key employees
  • Extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities
  • Litigation, including product liability claims
  • Foreign currency fluctuations
  • Potential write-offs of goodwill and other intangible assets
  • Changes in tax legislation and tax rates
  • Differing interests of voting and non-voting shareholders
  • Numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady's Form 10-K for the year ended July 31, 2022.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

Market risk

As filed, 158 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Refer to the Company’s annual report on Form 10-K for the year ended July 31, 2022. There has been no material change in this information since July 31, 2022.

Controls and procedures

As filed, 1,802 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Brady Corporation maintains a set of disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports the Company files under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of its management, including its President and Chief Executive Officer and its Chief Financial Officer and Treasurer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based on that evaluation, the Company’s President & Chief Executive Officer and Chief Financial Officer and Treasurer concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this report.

There were no changes in the Company's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the Company's most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Risk factors

As filed, 356 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company’s business, results of operations, financial condition, and cash flows are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” of Company’s annual report on Form 10-K for the year ended July 31, 2022. There have been no material changes from the risk factors set forth in the 2022 Form 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-10-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-08-01 to 2022-10-31$322.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-08-01 to 2022-10-31$167.3mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2022-08-01 to 2022-10-31$155.3mus-gaap:GrossProfit
Research and development3 months2022-08-01 to 2022-10-31$13.9mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2022-08-01 to 2022-10-31$89.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-08-01 to 2022-10-31$51.4mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-08-01 to 2022-10-31$894.0kus-gaap:InterestExpense
Income tax3 months2022-08-01 to 2022-10-31$10.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-08-01 to 2022-10-31$39.4mus-gaap:NetIncomeLoss
Diluted shares (weighted)3 months2022-08-01 to 2022-10-3150,090,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2022-08-01 to 2022-10-31$28.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-08-01 to 2022-10-31$3.9mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2022-08-01 to 2022-10-31$11.4mus-gaap:PaymentsOfDividends
Share repurchases3 months2022-08-01 to 2022-10-31$12.1mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-10-31$114.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-10-31$503.3mus-gaap:AssetsCurrent
Total assetsAt period end2022-10-31$1.35bnus-gaap:Assets
Current liabilitiesAt period end2022-10-31$243.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-10-31$438.9mus-gaap:Liabilities
Shareholders' equityAt period end2022-10-31$911.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000746598-22-000148. Last ingested by Listed: Nov 9, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.